Stocks
Revance Therapeutics, Inc.RVNC
NASDAQHealthcareBiotechnology$3.65+0.00%
Specializing in innovative aesthetic and therapeutic treatments, this biotechnology company focuses on developing neuromodulator products for medical and cosmetic applications. Investors closely monitor its pipeline advancements and regulatory milestones, particularly its FDA-approved product for frown lines and ongoing trials for other indications.
Market Cap: $381.0M52W Range: $2.30 – $7.56
Congressional Interest in Revance Therapeutics, Inc. (RVNC)
1 member of Congress has disclosed 1 trade in Revance Therapeutics, Inc. (RVNC), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading RVNC?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-10-04 | Thomas R Carper | buy | $1K – $15K |